Enovix Batteries Chosen for FDA-Approved Accurate Mini Blood Pressure Monitor
25 September 2023 - 1:30PM
Enovix Corporation (“Enovix”) (Nasdaq: ENVX), an advanced silicon
battery company, today announced its standard IoT and
Wearable-sized batteries have been chosen by Accurate Meditech for
their Class II FDA-Approved “Mini” multi-vital sign monitor.
The Accurate Mini continuously monitors blood pressure, pulse
rate and other vital signs. Accurate Meditech received FDA
clearance in June 2023. With an Enovix battery, the Mini is
anticipated to last over four months on a single charge, a 35%
improvement compared to standard graphite batteries. It will be
available over the counter and sold at CVS, Walgreens and Walmart
in the U.S. in the second half of 2024.
“We chose Enovix due to its long-lasting battery because it’s
critical that our device runs as many hours as possible so that
people can continuously monitor the status of their heart and other
vital signs,” said Stanley Wang, General Manager of Accurate
Meditech. “Non-invasive health monitoring is efficient and
effective and with more than 80 million people in the United States
suffering from cardiovascular disease, working with Enovix, we’re
pleased to play a role in helping minimize risks with always-on,
worry-free health monitoring.”
The Accurate Mini includes the Enovix standard-sized IoT and
Wearable cell, which has 322 mAh of capacity, 1.17 Wh energy and
can be cycled over 500 times to 80% capacity retention. This cell
received multiple safety certifications including UN38.3 and
IEC-62133-2.
“We are proud to collaborate with Accurate Meditech to push the
boundaries of non-invasive health monitoring and battery life for
IoT and wearable devices like the Accurate Mini,” said Dr. Raj
Talluri, President & CEO of Enovix. “This achievement marks an
important milestone in our journey to scale and is just the
beginning of our customer design wins, further validating the
positive impact Enovix technology can have on people’s day-to-day
lives.”
For more details, please contact Enovix Customer Support
(customersupport@enovix.com) and visit our
website: www.enovix.com. Enovix cell testing guide can be
found here.
More information on Accurate Meditech can be found here.
About EnovixEnovix is on a mission to power the
technologies of the future. Everything from IoT, mobile and
computing devices, to the vehicle you drive, needs a better
battery. The company’s disruptive architecture enables a battery
with high energy density and capacity without compromising safety.
Enovix is scaling its silicon-anode, lithium-ion battery
manufacturing capabilities to meet customer demand. For more
information visit www.enovix.com and follow us on LinkedIn.
Forward Looking Statements This press release
contains forward-looking statements within the meaning of Section
27A of the Securities Act of 1933, as amended, and Section 21E of
the Securities Exchange Act of 1934, as amended, about us and our
industry that involve substantial risks and uncertainties.
Forward-looking statements include, but are not limited to, the
availability of products; the customer demand for products; and
Enovix’s ability to sell into the IOT and wearable markets.
Forward-looking statements are predictions, projections,
expectations and other statements about future events that are
based on current expectations and assumptions and, as a result, are
subject to significant risks and uncertainties. Actual results
could differ materially from these forward-looking statements as a
result of certain risks and uncertainties. For additional
information on these risks and uncertainties and other potential
factors that could affect our business and financial results or
cause actual results to differ from the results predicted, please
refer to our filings with the Securities and Exchange Commission
(the “SEC”), including in the “Risk Factors” and “Management’s
Discussion and Analysis of Financial Condition and Results of
Operations” sections of our most recently filed annual periodic
reports on Form 10-K and quarterly report on Form 10-Q and other
documents that we have filed, or that we will file, with the SEC.
Any forward-looking statements made by us in this press release
speak only as of the date on which they are made and subsequent
events may cause these expectations to change. We disclaim any
obligations to update or alter these forward-looking statements in
the future, whether as a result of new information, future events
or otherwise, except as required by law.
For media inquiries, please contact:
Enovix CorporationKristin AtkinsPhone: +1 (650) 815-6934Email:
katkins@enovix.com
For investor inquiries, please contact:
Enovix CorporationCharles AndersonPhone: +1 (612) 229-9729Email:
canderson@enovix.com
A photo accompanying this announcement is available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/756a5e2c-4698-496c-8b7d-179d577f5369
Enovix (NASDAQ:ENVX)
Historical Stock Chart
Von Mai 2024 bis Jun 2024
Enovix (NASDAQ:ENVX)
Historical Stock Chart
Von Jun 2023 bis Jun 2024